Cognizant (CTSH) Q4 2025 earnings review
Winner's Circle Achieved: Financial Services Leads the Charge
Cognizant delivered a strong finish to 2025, beating the high end of guidance with $5.33B in Q4 revenue (+4.9% YoY). The company declared it has returned to the 'Winner's Circle' two years ahead of schedule. The standout driver was a massive resurgence in Financial Services (+10.5%), enabling the company to absorb continued weakness in CMT. Profitability improved with Adjusted Operating Margin expanding 30 bps to 16.0%. Management issued constructive FY26 guidance calling for 4.0-6.5% constant currency growth and further margin expansion, signaling confidence that the pivot to growth is sustainable.
🐂 Bull Case
Financial Services, the company's largest segment (~30% of rev), accelerated dramatically to 10.5% YoY growth (9.3% CC). This double-digit surge confirms a robust recovery in discretionary spending and validates the company's modernization strategy.
Cognizant signed 28 large deals (TCV >$100M) in 2025, with TCV growth of nearly 50% YoY. Q4 bookings rose 9% YoY, rebounding from a Q3 dip, driving TTM bookings to $28.4B (1.3x book-to-bill).
🐻 Bear Case
While P&R grew 1.8% reported, the Belcan acquisition contributed significantly (approx. 960 bps to P&R for the full year). This implies organic P&R performance remains deeply negative, weighed down by discrete manufacturing and macro headwinds.
Communications, Media & Technology continues to shrink, posting -0.4% reported growth (-1.2% CC). Despite the overall company turnaround, this segment has yet to find a floor.
⚖️ Verdict: 🟢
Bullish. The resurgence of Financial Services is a game-changer, offsetting pockets of weakness elsewhere. With margins expanding and bookings accelerating, the FY26 outlook appears achievable. The primary risk remains the organic health of P&R masked by M&A.
Key Themes
Financial Services Acceleration
Accelerating. Financial Services has transformed from a laggard to the primary growth engine. Growth accelerated from +0.7% in Q3 to +10.5% in Q4 (reported). Management cited digital engineering, legacy modernization, and a return of discretionary spend as key drivers.
Bookings Rebound
Reversing. After a worrying 5% dip in Q3, bookings rebounded strongly in Q4, growing 9% YoY. Trailing 12-month bookings reached $28.4B (+5%), supporting the FY26 revenue guidance range. The pipeline conversion appears to have stabilized.
Masked Weakness in Products & Resources
Decelerating. Reported P&R growth slowed to 1.8% in Q4 from 11.3% in Q3. Crucially, the Belcan acquisition (closed mid-year) contributed heavily to this segment (~960bps for the full year). The sharp Q4 deceleration suggests the inorganic boost is lapping or organic weakness has intensified significantly.
CMT Sector Headwinds
Stable (Negative). Communications, Media & Technology revenue declined 0.4% YoY. While an improvement from the deeper declines seen in early 2024, it remains the only segment in contraction, limiting overall topline potential.
Operational Efficiency & Margins
Improving. Despite investments in AI and M&A integration, Adjusted Operating Margin expanded to 16.0% in Q4 (+30 bps YoY) and 15.8% for FY25 (+50 bps). This demonstrates effective cost control and operating leverage, validating the 'operational rigor' theme management emphasizes.
AI Builder Strategy & Partnerships
Management highlighted the 'AI Builder' strategy, noting 28 large deals signed in 2025. Partnerships with NVIDIA, Microsoft, and the new collaboration with Anthropic are central to moving clients from AI experimentation to scaled implementation.
Other KPIs
Expanded 50 basis points YoY, hitting the top end of expectations. Management projects further expansion to 15.9%-16.1% in FY26, indicating continued operational efficiency gains.
Strong conversion at 120% of Net Income (vs 82% in 2024). This fueled $2.0B in shareholder returns ($1.4B buybacks, $0.6B dividends). Cash position remains robust at $1.9B.
Beat consensus and grew 11.6% YoY from $1.21 in 24Q4. The beat was driven by revenue overperformance and margin discipline.
Guidance
Stable/Accelerating. Implies 4.0% to 6.5% growth in constant currency. This includes ~150bps of inorganic contribution (50bps from future/closed M&A). Organic growth outlook is constructive compared to peers.
Accelerating. Targets 10-30 basis points of expansion over FY25's 15.8%. Management is effectively balancing AI investments with efficiency.
Accelerating. Implies 5-8% YoY growth. This aligns with the revenue growth + margin expansion + share buyback algorithm.
Decelerating (sequentially). Represents 2.7% to 4.2% YoY CC growth. The sequential flatness reflects typical Q1 seasonality, though YoY trends remain positive.
Key Questions
Products & Resources Organic Health
With Belcan contributing significantly to P&R, and the segment only growing 1.8% reported in Q4, what is the organic growth rate? Is the core manufacturing/retail business contracting, and when will it stabilize?
AI Monetization Specifics
Management cites 'AI Builder' momentum, but how much of the Q4 revenue or bookings is directly attributable to GenAI projects versus traditional modernization?
CMT Turnaround Timing
Communications, Media & Technology remains negative (-0.4%). What are the leading indicators (bookings, pipeline) that suggest this vertical will return to growth in FY26?
Belcan Synergies
Now that Belcan has been integrated for several months, are you seeing revenue synergies (cross-selling to industrial clients) or is it primarily a standalone contribution?